These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 15312134

  • 1. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S.
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [Abstract] [Full Text] [Related]

  • 2. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
    Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, Motoki K, Kuranaga N, Fukasawa M, Shinomiya N, Seki S.
    J Immunol; 2002 Dec 01; 169(11):6127-32. PubMed ID: 12444115
    [Abstract] [Full Text] [Related]

  • 3. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I.
    Hepatology; 1999 Aug 01; 30(2):430-6. PubMed ID: 10421651
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.
    Hashimoto W, Takeda K, Anzai R, Ogasawara K, Sakihara H, Sugiura K, Seki S, Kumagai K.
    J Immunol; 1995 May 01; 154(9):4333-40. PubMed ID: 7722291
    [Abstract] [Full Text] [Related]

  • 5. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
    Habu Y, Shinomiya N, Kinoshita M, Matsumoto A, Kawabata T, Seki S.
    Clin Exp Med; 2007 Mar 01; 7(1):30-8. PubMed ID: 17380303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice.
    Inui T, Nakashima H, Habu Y, Nakagawa R, Fukasawa M, Kinoshita M, Shinomiya N, Seki S.
    J Hepatol; 2005 Oct 01; 43(4):670-8. PubMed ID: 15922476
    [Abstract] [Full Text] [Related]

  • 8. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K.
    Eur J Immunol; 2001 Jun 01; 31(6):1720-7. PubMed ID: 11385616
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
    Kawamura T, Seki S, Takeda K, Narita J, Ebe Y, Naito M, Hiraide H, Abo T.
    Cell Immunol; 1999 May 01; 193(2):219-25. PubMed ID: 10222065
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S.
    J Immunol; 2001 Jun 01; 166(11):6578-84. PubMed ID: 11359810
    [Abstract] [Full Text] [Related]

  • 11. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M, Yu WG, Ahn HJ, Yamashita M, Yang YF, Ono S, Hamaoka T, Kawano T, Taniguchi M, Koezuka Y, Fujiwara H.
    J Immunol; 1999 Jul 01; 163(1):93-101. PubMed ID: 10384104
    [Abstract] [Full Text] [Related]

  • 12. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, Ikeda H, Nishimura T.
    Immunol Lett; 2004 Aug 15; 95(1):5-11. PubMed ID: 15325792
    [Abstract] [Full Text] [Related]

  • 13. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo.
    Ito H, Ando K, Nakayama T, Taniguchi M, Ezaki T, Saito K, Takemura M, Sekikawa K, Imawari M, Seishima M, Moriwaki H.
    Hepatology; 2003 Nov 15; 38(5):1116-24. PubMed ID: 14578850
    [Abstract] [Full Text] [Related]

  • 14. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.
    Takeda K, Seki S, Ogasawara K, Anzai R, Hashimoto W, Sugiura K, Takahashi M, Satoh M, Kumagai K.
    J Immunol; 1996 May 01; 156(9):3366-73. PubMed ID: 8617962
    [Abstract] [Full Text] [Related]

  • 15. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, Azuma M, Takeda K, Akira S, Saito A.
    Infect Immun; 2001 Nov 01; 69(11):6643-50. PubMed ID: 11598033
    [Abstract] [Full Text] [Related]

  • 16. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
    Kajiwara T, Tomita Y, Okano S, Iwai T, Yasunami Y, Yoshikai Y, Nomoto K, Yasui H, Tominaga R.
    Transplantation; 2007 Jan 27; 83(2):184-92. PubMed ID: 17264815
    [Abstract] [Full Text] [Related]

  • 17. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K, Yanagawa Y, Iwabuchi K, Namba K, Kitaichi N, Ohno S, Onoé K.
    Immunology; 2008 May 27; 124(1):102-11. PubMed ID: 18194275
    [Abstract] [Full Text] [Related]

  • 18. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.
    Takahashi M, Ogasawara K, Takeda K, Hashimoto W, Sakihara H, Kumagai K, Anzai R, Satoh M, Seki S.
    J Immunol; 1996 Apr 01; 156(7):2436-42. PubMed ID: 8786302
    [Abstract] [Full Text] [Related]

  • 19. Critical role of NK1+ T cells in IL-12-induced immune responses in vivo.
    Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Van Kaer L, Yagita H, Abo T, Okumura K.
    J Immunol; 1998 Jan 01; 160(1):16-9. PubMed ID: 9551949
    [Abstract] [Full Text] [Related]

  • 20. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
    Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, Watanabe H, Hiraide H, Uchiyama M, Abo T.
    J Immunol; 1997 Aug 01; 159(3):1537-42. PubMed ID: 9233653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.